Notably, we showed that at the same dose of smTRAIL (8 mg/kg), insensitive tumor CT26 cells secreted more CCL2 and recruited more macrophages than sensitive 4T1 cells, which may support tumor growth. The gene discussed is CCL2; the disease is neoplasm.